Uterine Fibroids

Latest News

Relugolix combination therapy effective against symptomatic uterine fibroids
Relugolix combination therapy effective against symptomatic uterine fibroids

March 24th 2023

In a recent study, women with symptomatic uterine fibroids saw reduced symptom burden and improved quality of life after 24 weeks of treatment through relugolix combination therapy.

Uterine artery embolization versus myomectomy to treat uterine fibroids
Uterine artery embolization versus myomectomy to treat uterine fibroids

June 13th 2022

Open-ended interviews shed light on US women’s perspective of fibroid burden
Open-ended interviews shed light on US women’s perspective of fibroid burden

June 10th 2022

Detecting cervical pathology in women with uterine fibroids via colposcopy
Detecting cervical pathology in women with uterine fibroids via colposcopy

June 6th 2022

FDA accepts Myfembree sNDA for bleeding associated with uterine fibroids
FDA accepts Myfembree sNDA for bleeding associated with uterine fibroids

June 2nd 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.